Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase

Background and Aims: HCC risk in chronic hepatitis B (CHB) is higher in the indeterminate phase compared with the inactive phase. However, it is unclear if antiviral therapy reduces HCC risk in this population. We aimed to evaluate the association between antiviral therapy and HCC risk in the indete...

Full description

Saved in:

Bibliographic Details
Published in:	Hepatology (Baltimore, Md.) Vol. 78; no. 5; pp. 1558 - 1568
Main Authors:	Huang, Daniel Q., Tran, Andrew, Yeh, Ming-Lun, Yasuda, Satoshi, Tsai, Pei-Chien, Huang, Chung-Feng, Dai, Chia Yen, Ogawa, Eiichi, Ishigami, Masatoshi, Ito, Takanori, Kozuka, Ritsuzo, Enomoto, Masaru, Suzuki, Takanori, Yoshimaru, Yoko, Preda, Carmen M., Marin, Raluca I., Sandra, Irina, Tran, Sally, Quek, Sabrina X.Z., Khine, Htet Htet Toe Wai, Itokawa, Norio, Atsukawa, Masanori, Uojima, Haruki, Watanabe, Tsunamasa, Takahashi, Hirokazu, Inoue, Kaori, Maeda, Mayumi, Hoang, Joseph K., Trinh, Lindsey, Barnett, Scott, Cheung, Ramsey, Lim, Seng Gee, Trinh, Huy N., Chuang, Wan-Long, Tanaka, Yasuhito, Toyoda, Hidenori, Yu, Ming-Lung, Nguyen, Mindie H.
Format:	Journal Article
Language:	English
Published:	Hagerstown, MD Lippincott Williams & Wilkins 01.11.2023
Subjects:	Adult Alanine Transaminase Antiviral Agents - therapeutic use Carcinoma, Hepatocellular - epidemiology Carcinoma, Hepatocellular - etiology Carcinoma, Hepatocellular - prevention & control DNA, Viral Female Hepatitis B - complications Hepatitis B e Antigens Hepatitis B virus - genetics Hepatitis B, Chronic - complications Hepatitis B, Chronic - drug therapy Hepatitis B, Chronic - epidemiology Humans Liver Neoplasms - epidemiology Liver Neoplasms - etiology Liver Neoplasms - prevention & control Male Middle Aged
ISSN:	0270-9139, 1527-3350, 1527-3350
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!